Related references
Note: Only part of the references are listed.An epigenetic mechanism of resistance to targeted therapy in T cell acute lymphoblastic leukemia
Birgit Knoechel et al.
NATURE GENETICS (2014)
T-cell acute lymphoblastic leukaemia: recent molecular biology findings
Monika D. Kraszewska et al.
BRITISH JOURNAL OF HAEMATOLOGY (2012)
The molecular basis of T cell acute lymphoblastic leukemia
Pieter Van Vlierberghe et al.
JOURNAL OF CLINICAL INVESTIGATION (2012)
Preclinical Analysis of the γ-Secretase Inhibitor PF-03084014 in Combination with Glucocorticoids in T-cell Acute Lymphoblastic Leukemia
Jeremy B. Samon et al.
MOLECULAR CANCER THERAPEUTICS (2012)
Notch in T-ALL: new players in a complex disease
Ute Koch et al.
TRENDS IN IMMUNOLOGY (2011)
Characterization of an Atypical γ-Secretase Complex from Hematopoietic Origin
Lisa Placanica et al.
BIOCHEMISTRY (2010)
Evaluation of Selective gamma-Secretase Inhibitor PF-03084014 for Its Antitumor Efficacy and Gastrointestinal Safety to Guide Optimal Clinical Trial Design
Ping Wei et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Targeting the Notch1 and mTOR pathways in a mouse T-ALL model
Kathleen Cullion et al.
BLOOD (2009)
Down-regulation of the Notch pathway mediated by a γ-secretase inhibitor induces anti-tumour effects in mouse models of T-cell leukaemia
J. Tammam et al.
BRITISH JOURNAL OF PHARMACOLOGY (2009)
Inhibition of NOTCH Signaling by Gamma Secretase Inhibitor Engages the RB Pathway and Elicits Cell Cycle Exit in T-Cell Acute Lymphoblastic Leukemia Cells
Sudhir S. Rao et al.
CANCER RESEARCH (2009)
Dual antitumor mechanisms of Notch signaling inhibitor in a T-cell acute lymphoblastic leukemia xenograft model
Shigeo Masuda et al.
CANCER SCIENCE (2009)
gamma-secretase inhibitors reverse glucocorticoid resistance in T cell acute lymphoblastic leukemia
Pedro J. Real et al.
NATURE MEDICINE (2009)
gamma-secretase inhibitors enhance taxane-induced mitotic arrest and apoptosis in colon cancer cells
Takashi Akiyoshi et al.
GASTROENTEROLOGY (2008)
In vitro validation of γ-secretase inhibitors alone or in combination with other anti-cancer drugs for the treatment of T-cell acute lymphoblastic leukemia
Kim De Keersmaecker et al.
HAEMATOLOGICA (2008)
Alzheimer's presenilin 1 causes chromosome missegregation and aneuploidy
Debrah I. Boeras et al.
NEUROBIOLOGY OF AGING (2008)
Mutational loss of PTEN induces resistance to NOTCH1 inhibition in T-cell leukemia
Teresa Palomero et al.
NATURE MEDICINE (2007)
FBW7 mutations in leukemic cells mediate NOTCH pathway activation and resistance to γ-secretase inhibitors
Jennifer O'Neil et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2007)
Notch signals positively regulate activity of the mTOR pathway in T-cell acute lymphoblastic leukemia
Steven M. Chan et al.
BLOOD (2007)
NOTCH1-induced T-cell leukemia in transgenic zebrafish
J. Chen et al.
LEUKEMIA (2007)
Apoptosis in T cell acute lymphoblastic leukemia cells after cell cycle arrest induced by pharmacological inhibition of notch signaling
Huw D. Lewis et al.
CHEMISTRY & BIOLOGY (2007)
Notch 1 activation in the molecular pathogenesis of T-cell acute lymphoblastic leukaemia
C Grabher et al.
NATURE REVIEWS CANCER (2006)
Drug therapy - Treatment of acute lymphoblastic leukemia
CH Pui et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Mastermind critically regulates Notch-mediated lymphoid cell fate decisions
I Maillard et al.
BLOOD (2004)
Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia
AP Weng et al.
SCIENCE (2004)
Characterization of childhood acute lymphoblastic leukemia xenograft models for the preclinical evaluation of new therapies
NLM Liem et al.
BLOOD (2004)
Resistance to different classes of drugs is associated with impaired apoptosis in childhood acute lymphoblastic leukemia
A Holleman et al.
BLOOD (2003)
Growth suppression of pre-T acute lymphoblastic leukemia cells by inhibition of notch signaling
AP Weng et al.
MOLECULAR AND CELLULAR BIOLOGY (2003)
Share Paper
